Alvotech Stock After Earnings Loss What Changed

Alvotech reported results for the nine months ended September 30, 2026, moving from net income of US$136.47 million a year earlier to a net loss of US$140.66 million, with basic and diluted earnings swinging from US$0.47 per share to a loss of US$0.45 per share from continuing operations. The swing into loss highlights how current operating pressures, including costs and execution around Alvotech's biosimilar platform, are weighing on profitability at a time when the business model relies...

Nov 15, 2026 - 12:00
 0  3
Alvotech Stock After Earnings Loss What Changed
Alvotech reported results for the nine months ended September 30, 2026, moving from net income of US$136.47 million a year earlier to a net loss of US$140.66 million, with basic and diluted earnings swinging from US$0.47 per share to a loss of US$0.45 per share from continuing operations. The swing into loss highlights how current operating pressures, including costs and execution around Alvotech's biosimilar platform, are weighing on profitability at a time when the business model relies...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow